Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-29 Purchase | 2021-07-01 6:29 pm | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 187,500 | $16 | $3,000,000 | 2,834,910 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:35 pm | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 1,142,857 | $1.75 | $2,000,000 | 3,159,879 (Indirect Direct) | View |
| 2019-07-15 Purchase | 2019-07-15 4:15 pm | SUNESIS PHARMACEUTICALS INC | SNSS | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N ELMS STEVE 10% Owner | 2,500,000 | $0.6 | $1,500,000 | 10,100,000 (Indirect) | View |
| 2018-07-10 Sale | 2018-07-12 4:45 pm | Loxo Oncology Inc. | LOXO | AISLING CAPITAL III LP Aisling Capital Partners III LP Aisling Capital Partners III LLC ELMS STEVE SCHIFF ANDREW N Purcell Dennis J 10% Owner | 1,400,000 | $179.43 | $251,202,000 | 2,038,920 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-17 Option Award | 2022-06-22 6:43 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 15,619 | $0 | 15,619 (Indirect) | View |
| 2022-05-24 Option Award | 2022-05-26 4:09 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 5:59 pm | N/A 2032-03-07 | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 79,758 | $0 | 3,695,429 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 6:29 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 12,288,426 | $0 | 2,834,910 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:18 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
| 2021-06-24 Ownership | 2021-06-24 6:32 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner | 0 | $0 | 2,647,410 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:38 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 45,000 | $0 | 2,770,726 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:55 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 12,658 | $0 | 3,172,537 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 9:02 pm | N/A 2031-02-25 | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-12-31 Ownership | 2021-02-12 5:12 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 0 | $0 | 2,017,022 (Indirect) | View |
| 2020-12-31 Ownership | 2021-02-12 5:12 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 17,022 | $0 | 2,017,022 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:47 pm | N/A N/A | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 7,500 | $0 | 2,725,766 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:10 pm | N/A 2030-06-02 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-02-28(A) Option Award | 2020-05-01 5:12 pm | N/A N/A | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 7:11 pm | N/A 2030-02-28 | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-06 10:23 am | N/A N/A | Zosano Pharma Corp | ZSAN | Aisling Capital IV LP Aisling Capital Partners IV LP Aisling Capital Partners IV LLC ELMS STEVE SCHIFF ANDREW N 10% Owner | 689,655 | $1.45 | 2,718,226 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 5:07 pm | N/A 2029-08-06 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-08-06 Ownership | 2019-08-08 5:06 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 0 | $0 | 3,500,000 (Indirect) | View |
| 2019-01-02 Option Award | 2019-07-18 4:07 pm | N/A 2029-01-02 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director 10% Owner | 1,500 | $0 | 1,500 (Direct) | View |
| 2019-04-11 Option Award | 2019-04-12 4:15 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Aisling Capital IV LP Aisling Capital Partners IV LP Aisling Capital Partners IV LLC ELMS STEVE SCHIFF ANDREW N 10% Owner | 428,571 | $3.5 | 2,028,571 (Direct) | View |
| 2019-03-13 Option Award | 2019-03-15 5:01 pm | N/A 2029-03-13 | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2019-02-15 Disposition | 2019-02-15 09:09 am | N/A 2024-07-30 | Loxo Oncology Inc. | LOXO | ELMS STEVE Director 10% Owner | 50,999 | $235 | 2,038,920 (Direct) | View |
| 2019-02-15 Equity Swap | 2019-02-15 09:09 am | N/A N/A | Loxo Oncology Inc. | LOXO | ELMS STEVE Director 10% Owner | 2,038,920 | $235 | 2,038,920 (Indirect) | View |
| 2019-01-23 Ownership | 2019-01-24 5:23 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N ELMS STEVE 10% Owner | 0 | $0 | 7,600,000 (Indirect) | View |
| 2018-06-22 Option Award | 2018-06-25 5:01 pm | N/A 2028-06-22 | ADMA BIOLOGICS Inc | ADMA | ELMS STEVE Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2018-06-13 Option Award | 2018-06-14 5:01 pm | N/A 2028-06-12 | Loxo Oncology Inc. | LOXO | ELMS STEVE Director 10% Owner | 8,750 | $0 | 8,750 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 8:16 pm | N/A 2028-05-17 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2018-03-29(A) Ownership | 2018-04-12 4:05 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Aisling Capital IV LP Aisling Capital Partners IV LP Aisling Capital Partners IV LLC ELMS STEVE SCHIFF ANDREW N 10% Owner | 0 | $0 | 1,600,000 (Direct) | View |
| 2018-03-29 Ownership | 2018-04-09 4:53 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Aisling Capital IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 0 | $0 | 1,600,000 (Direct) | View |